# RGS10

## Overview
RGS10 is a gene that encodes the protein regulator of G protein signaling 10, a member of the RGS family known for its role as a GTPase-activating protein (GAP) for Gα subunits. This protein is integral in modulating G protein-coupled receptor (GPCR) signaling pathways, thereby influencing various cellular processes such as signal transduction, cell proliferation, and autophagy (Almutairi2020Regulator). RGS10 is particularly significant in bone physiology, where it regulates osteoclast differentiation, and in the immune system, where it affects macrophage polarization and T cell function (Almutairi2020Regulator; Yang2007RGS10null). The protein's interactions with other cellular components, such as STIM2 and Gα subunits, underscore its role in diverse signaling pathways (Wendimu2021RGS10). Clinically, alterations in RGS10 expression are associated with diseases like osteopetrosis, multiple sclerosis, Parkinson's disease, and certain cancers, highlighting its potential as a therapeutic target (Almutairi2020Regulator; Lee2016Regulator; Yang2007RGS10null).

## Structure
RGS10 is a small regulator of G protein signaling protein, characterized by a conserved RGS domain that functions as a GTPase-activating protein (GAP) for the Gi family Gα subunits (Almutairi2020Regulator). The primary structure of RGS10 includes a single RGS domain and short disordered amino and carboxy-terminal extensions, which contain sites for regulatory modifications (Almutairi2020Regulator). The secondary structure of RGS10 features a shorter flexible αVI helix and an extended αV-αVI loop compared to other RGS domains (Almutairi2020Regulator).

RGS10 does not typically form a quaternary structure, functioning as a monomer. It undergoes several post-translational modifications, including phosphorylation, palmitoylation, and ubiquitination, which influence its stability, GAP activity, and subcellular localization (Almutairi2020Regulator). Phosphorylation on serine 168 by cAMP-dependent PKA affects its localization, while palmitoylation on cysteine 66 influences its GAP activity (Almutairi2020Regulator).

The Rgs10 gene undergoes alternative splicing, resulting in two isoforms: RGS10A, a 181 amino-acid peptide, and RGS10B, a 167 amino-acid peptide. RGS10A is the predominant and functional isoform, whereas RGS10B has impaired GAP function due to the absence of 14 amino acids at the N-terminus (Almutairi2020Regulator).

## Function
RGS10 is a member of the regulator of G protein signaling (RGS) family, which modulates G protein-coupled receptor (GPCR) signaling pathways by acting as a GTPase-activating protein (GAP) for Gα subunits. This activity accelerates the termination of GPCR signaling, playing a crucial role in maintaining cellular homeostasis (Almutairi2020Regulator). RGS10 is involved in various cellular processes, including signal transduction, cell proliferation, and potentially autophagy, due to its broad expression in diverse cells and tissues (Almutairi2020Regulator).

In bone physiology, RGS10 is essential for osteoclast differentiation by regulating calcium oscillation and NFATc1 signaling, which are critical for osteoclastogenesis (Yang2007RGS10null). It acts downstream of ITAM and upstream of calcineurin in the RANKL-induced calcium oscillation-calcineurin-NFATc1 pathway, interacting with calmodulin in a calcium-dependent manner to regulate these oscillations (Yang2007RGS10null).

RGS10 is also highly expressed in leukocytes, particularly in monocytes/macrophages, where it modulates macrophage polarization by suppressing M1 activation and promoting M2 phenotype markers. It influences inflammasome activity in macrophages and affects T cell adhesion and migration by regulating chemokine-induced signaling pathways (Almutairi2020Regulator). In the cardiovascular system, RGS10 acts as a cardioprotective protein by inhibiting signaling pathways downstream of the Angiotensin II receptor, potentially preventing cardiac hypertrophy (Almutairi2020Regulator).

## Clinical Significance
Mutations and alterations in the expression of the RGS10 gene have been implicated in several diseases. In bone physiology, RGS10 is crucial for osteoclast differentiation. RGS10-null mutations lead to severe osteopetrosis, characterized by increased bone mass due to impaired osteoclast differentiation, while osteoblast function remains unaffected (Yang2007RGS10null). This condition results from disrupted calcium signaling pathways essential for osteoclast function (Yang2007RGS10null).

In the context of neuroinflammatory and neurodegenerative diseases, RGS10 is involved in modulating immune responses. Altered expression of RGS10 has been linked to multiple sclerosis (MS) and Parkinson's disease. In MS, higher mRNA levels of RGS10 are observed in patients, and its deficiency in experimental models reduces disease severity, suggesting a role in autoimmune responses (Lee2016Regulator).

RGS10 also plays a role in cancer, particularly in ovarian cancer, where its reduced expression is associated with chemoresistance and poor prognosis. It affects inflammatory signaling pathways and is linked to drug resistance through the Rheb-GTP/mTOR pathway (Almutairi2020Regulator). These findings highlight the potential of RGS10 as a therapeutic target in various pathological conditions.

## Interactions
RGS10 interacts with several proteins and plays a significant role in various cellular processes. It physically interacts with stromal interaction molecule 2 (STIM2) in microglia, a crucial interaction for regulating pro-inflammatory gene expression through the store-operated calcium entry (SOCE) pathway (Wendimu2021RGS10). This interaction is stable and calcium-insensitive, not requiring calmodulin (CaM) (Wendimu2021RGS10). RGS10 also interacts with guanine nucleotide-binding protein subunits Gαi2 and Gαi3, influencing G protein signaling (Wendimu2021RGS10).

In platelets, RGS10 forms a complex with spinophilin (SPL) and SHP-1 protein tyrosine phosphatase, which dissociates upon activation, increasing free RGS10 levels to limit G protein signaling (Almutairi2020Regulator). RGS10 also interacts with the 14-3-3γ scaffolding protein in resting platelets (Almutairi2020Regulator). In the context of cancer, RGS10 interacts with the monomeric GTP-binding Rheb protein, affecting mTORC1 activity and potentially influencing chemoresistance (Almutairi2020Regulator). These interactions highlight RGS10's role in modulating immune responses, cellular signaling, and disease processes.


## References


[1. (Almutairi2020Regulator) Faris Almutairi, Jae-Kyung Lee, and Balázs Rada. Regulator of g protein signaling 10: structure, expression and functions in cellular physiology and diseases. Cellular Signalling, 75:109765, November 2020. URL: http://dx.doi.org/10.1016/j.cellsig.2020.109765, doi:10.1016/j.cellsig.2020.109765. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2020.109765)

[2. (Lee2016Regulator) Jae-Kyung Lee and Josephine Bou Dagher. Regulator of g-protein signaling (rgs)1 and rgs10 proteins as potential drug targets for neuroinflammatory and neurodegenerative diseases. The AAPS Journal, 18(3):545–549, February 2016. URL: http://dx.doi.org/10.1208/s12248-016-9883-4, doi:10.1208/s12248-016-9883-4. This article has 24 citations.](https://doi.org/10.1208/s12248-016-9883-4)

[3. (Wendimu2021RGS10) Menbere Y. Wendimu, Mohammed Alqinyah, Stephen Vella, Phillip Dean, Faris Almutairi, Roseanne Davila-Rivera, Shima Rayatpisheh, James Wohlschlegel, Silvia Moreno, and Shelley B. Hooks. Rgs10 physically and functionally interacts with stim2 and requires store-operated calcium entry to regulate pro-inflammatory gene expression in microglia. Cellular Signalling, 83:109974, July 2021. URL: http://dx.doi.org/10.1016/j.cellsig.2021.109974, doi:10.1016/j.cellsig.2021.109974. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2021.109974)

[4. (Yang2007RGS10null) Shuying Yang and Yi-Ping Li. Rgs10-null mutation impairs osteoclast differentiation resulting from the loss of [ca2+]i oscillation regulation. Genes &amp; Development, 21(14):1803–1816, July 2007. URL: http://dx.doi.org/10.1101/gad.1544107, doi:10.1101/gad.1544107. This article has 112 citations.](https://doi.org/10.1101/gad.1544107)